Home›People›Steven Tablak
Steven Tablak

Steven Tablak

Director at Inflammatix

Director
Updated Nov 19, 2026·Latest SEC filing Nov 19, 2026·Suggest an edit

About Steven Tablak

Steven Tablak is a director of Inflammatix. The company develops rapid immune-response tests to help physicians diagnose acute infections and sepsis. He formerly served as GeneWeave's chairman and chief executive officer.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Steven Tablak in the role, so the role may have started earlier or lasted longer.

Inflammatix, Inc. Current
Former Chairman and CEO, GeneWeave
2020 – Present · Sunnyvale, CA
Inflammatix helps emergency teams identify infection type and illness severity from the body's immune response.
GeneWeave
Former Chairman and CEO

Key Colleagues at Startups

The people Steven Tablak works with at each company, as listed on that company's latest Form D.

Inflammatix, Inc. · Form D, Nov 19, 2026
Timothy Sweeney
Timothy Sweeney
Co-Founder and CEO, director
FK
Florian Kainzinger
Founder, Think.Health Ventures and director
IC
Ingo Chakravarty
Operating Partner at Northpond Ventures and director
JR
Jonathan Romanowsky
Co-Founder and director
David Persing
David Persing
EVP/Chief Medical Officer, Cepheid and director

Sources

  1. SECInflammatix, Inc. Form D, filed Nov 19, 2026
  2. P2Inflammatix | Interpreting the immune response to better diagnose disease